|
1
|
van den Brandt PA, Spiegelman D, Yaun SS,
et al: Pooled analysis of prospective cohort studies on height,
weight, and breast cancer risk. Am J Epidemiol. 152:514–527.
2000.PubMed/NCBI
|
|
2
|
Lahmann PH, Hoffmann K, Allen N, et al:
Body size and breast cancer risk: findings from the European
Prospective Investigation into Cancer and Nutrition (EPIC). Int J
Cancer. 111:762–771. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reeves GK, Pirie K, Beral V, Green J,
Spencer E and Bull D: Cancer incidence and mortality in relation to
body mass index in the Million Women Study: cohort study. BMJ.
335:11342007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iwasaki M, Otani T, Inoue M, Sasazuki S
and Tsugane S: Body size and risk for breast cancer in relation to
estrogen and progesterone receptor status in Japan. Ann Epidemiol.
17:304–312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Key TJ, Appleby PN, Reeves GK, et al: Body
mass index, serum sex hormones, and breast cancer risk in
postmenopausal women. J Natl Cancer Inst. 95:1218–1226. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Auwerx J and Staels B: Leptin. Lancet.
351:737–742. 1998. View Article : Google Scholar
|
|
7
|
Wu MH, Chou YC, Chou WY, et al:
Circulating levels of leptin, adiposity and breast cancer risk. Br
J Cancer. 100:578–582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soma D, Kitayama J, Yamashita H, Miyato H,
Ishikawa M and Nagawa H: Leptin augments proliferation of breast
cancer cells via transactivation of HER2. J Surg Res. 149:9–14.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saxena NK, Taliaferro-Smith L, Knight BB,
et al: Bidirectional crosstalk between leptin and insulin-like
growth factor-I signaling promotes invasion and migration of breast
cancer cells via transactivation of epidermal growth factor
receptor. Cancer Res. 68:9712–9722. 2008. View Article : Google Scholar
|
|
10
|
Cirillo D, Rachiglio AM, la Montagna R,
Giordano A and Normanno N: Leptin signaling in breast cancer: an
overview. J Cell Biochem. 105:956–964. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chua SC Jr, Chung WK, Wu-Peng XS, et al:
Phenotypes of mouse diabetes and rat fatty due to mutations in the
OB (leptin) receptor. Science. 271:994–996. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bray GA: The Zucker-fatty rat: a review.
Fed Proc. 36:148–153. 1977.
|
|
13
|
Rayner DV, Dalgliesh GD, Duncan JS, Hardie
LJ, Hoggard N and Trayhurn P: Postnatal development of the ob gene
system: elevated leptin levels in suckling fa/fa rats. Am J
Physiol. 273:R446–R450. 1997.PubMed/NCBI
|
|
14
|
Lee WM, Lu S, Medline A and Archer MC:
Susceptibility of lean and obese Zucker rats to tumorigenesis
induced by N-methyl-N-nitrosourea. Cancer Lett.
162:155–160. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hakkak R, Holley AW, Macleod SL, et al:
Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary
tumor development in female zucker rats. Breast Cancer Res.
7:R627–R633. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hakkak R, MacLeod S, Shaaf S, et al:
Obesity increases the incidence of
7,12-dimethylbenz(a)anthracene-induced mammary tumors in an
ovariectomized Zucker rat model. Int J Oncol. 30:557–563.
2007.PubMed/NCBI
|
|
17
|
de Assis S, Wang M, Goel S, Foxworth A,
Helferich W and Hilakivi-Clarke L: Excessive weight gain during
pregnancy increases carcinogen-induced mammary tumorigenesis in
Sprague-Dawley and lean and obese Zucker rats. J Nutr.
136:998–1004. 2006.PubMed/NCBI
|
|
18
|
Cho YM, Imai T, Takami S, Ogawa K and
Nishikawa A: Female heterozygous (+/fa) Zucker rats as a
novel leptin-related mammary carcinogenesis model. J Toxicol Sci.
37:1025–1034. 2012.
|
|
19
|
Phillips MS, Liu Q, Hammond HA, et al:
Leptin receptor missense mutation in the fatty Zucker rat. Nat
Genet. 13:18–19. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Imai T, Cho YM, Hasumura M and Hirose M:
Enhancement by acrylamide of
N-methyl-N-nitrosourea-induced rat mammary tumor
development-possible application for a model to detect co-modifiers
of carcinogenesis. Cancer Lett. 230:25–32. 2005.PubMed/NCBI
|
|
21
|
Cho YM, Imai T, Hasumura M and Hirose M:
Lack of enhancement of susceptibility to mammary and thyroid
carcinogenesis in rats exposed to DMBA and DHPN following
prepubertal iodine deficiency. Cancer Sci. 97:1031–1036. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ip C, Carter CA and Ip MM: Requirement of
essential fatty acid for mammary tumorigenesis in the rat. Cancer
Res. 45:1997–2001. 1985.PubMed/NCBI
|
|
23
|
Mauro L, Catalano S, Bossi G, et al:
Evidences that leptin up-regulates E-cadherin expression in breast
cancer: effects on tumor growth and progression. Cancer Res.
67:3412–3421. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thordarson G, Lee AV, McCarty M, et al:
Growth and characterization of
N-methyl-N-nitrosourea-induced mammary tumors in
intact and ovariectomized rats. Carcinogenesis. 22:2039–2047.
2001.PubMed/NCBI
|
|
25
|
Coutts AS and Murphy LC: Elevated
mitogen-activated protein kinase activity in estrogen-non
responsive human breast cancer cells. Cancer Res. 58:4071–4074.
1998.PubMed/NCBI
|
|
26
|
Gomez SL, Quach T, Horn-Ross PL, et al:
Hidden breast cancer disparities in Asian women: disaggregating
incidence rates by ethnicity and migrant status. Am J Public
Health. 100(Suppl 1): S125–S131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kalhan R, Puthawala K, Agarwal S, Amini SB
and Kalhan SC: Altered lipid profile, leptin, insulin, and
anthropometry in offspring of South Asian immigrants in the United
States. Metabolism. 50:1197–1202. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ghumare SS and Cunningham JE: Breast
cancer trends in Indian residents and emigrants portend an emerging
epidemic for India. Asian Pac J Cancer Prev. 8:507–512.
2007.PubMed/NCBI
|
|
29
|
Lim SE, Back M, Quek E, Iau P, Putti T and
Wong JE: Clinical observations from a breast cancer registry in
Asian women. World J Surg. 31:1387–1392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ishikawa M, Kitayama J and Nagawa H:
Enhanced expression of leptin and leptin receptor (OB-R) in human
breast cancer. Clin Cancer Res. 10:4325–4331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garofalo C, Koda M, Cascio S, et al:
Increased expression of leptin and the leptin receptor as a marker
of breast cancer progression: possible role of obesity-related
stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ray A, Nkhata KJ and Cleary MP: Effects of
leptin on human breast cancer cell lines in relationship to
estrogen receptor and HER2 status. Int J Oncol. 30:1499–1509.
2007.PubMed/NCBI
|
|
33
|
Iwasaki M, Otani T, Inoue M, Sasazuki S
and Tsugane S: Role and impact of menstrual and reproductive
factors on breast cancer risk in Japan. Eur J Cancer Prev.
16:116–123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grossmann ME, Ray A, Nkhata KJ, et al:
Obesity and breast cancer: status of leptin and adiponectin in
pathological processes. Cancer Metastasis Rev. 29:641–653. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hjartaker A, Langseth H and Weiderpass E:
Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med
Biol. 630:72–93. 2008. View Article : Google Scholar : PubMed/NCBI
|
